The clinical and economic impact of pharmaceutical care in end-stage renal disease patients.
about
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patternsA multidisciplinary program for achieving lipid goals in chronic hemodialysis patientsMedication-related problem type and appearance rate in ambulatory hemodialysis patientsMedication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis providerCost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings.Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi ArabiaDrug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center.Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach.Drug-related problem in children with chronic kidney disease.Pilot study of a pharmaceutical care intervention in an outpatient lung transplant clinic.Implementation and progress of clinical pharmacy in the rational medication use in a large tertiary hospital.The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.Assessment for chronic kidney disease service in high-risk patients at community health clinics.Outcomes of pharmacist-provided medication review in collaborative care for adult Singaporeans receiving hemodialysis.
P2860
Q24234308-4EE7E5B1-6252-48F7-81AE-ED954227DDCFQ24799624-7D630765-F579-4523-A3C8-6DAB82CD28E2Q24805292-5854B670-4DD9-4F3D-BC1E-F98A2CFBA5A6Q28168531-1521C803-C2C9-42D3-8B5C-584848BE90EDQ33572003-E0B2ED8B-ECAF-466F-BA23-27E81872E227Q34581506-9965D737-5AEC-460A-BFC1-7BAB2A948E2AQ35069892-DA406343-FB41-468D-AEC4-869F54F66E77Q37280811-BFDFEF00-7CD9-4E46-97DE-E06EFBF93EC1Q37997369-AEF92698-5BC1-4224-A055-0B90609B3B62Q38002977-6B25F328-10F7-48EB-921C-A6A609D9B387Q40113905-F9862315-075E-4A4E-80B4-8BFBA1251294Q41523902-D62992A1-E344-47C9-A67A-9AD8EDDB0B6CQ43272333-4C0D8D0D-57E6-446D-AEB0-9779604144EAQ45152649-9D492DFC-D001-4660-B5D7-3C48C76EDD36Q48204442-C3F1721B-4044-4C2B-9631-55E2720184AE
P2860
The clinical and economic impact of pharmaceutical care in end-stage renal disease patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The clinical and economic impa ...... -stage renal disease patients.
@ast
The clinical and economic impa ...... -stage renal disease patients.
@en
The clinical and economic impa ...... -stage renal disease patients.
@nl
type
label
The clinical and economic impa ...... -stage renal disease patients.
@ast
The clinical and economic impa ...... -stage renal disease patients.
@en
The clinical and economic impa ...... -stage renal disease patients.
@nl
prefLabel
The clinical and economic impa ...... -stage renal disease patients.
@ast
The clinical and economic impa ...... -stage renal disease patients.
@en
The clinical and economic impa ...... -stage renal disease patients.
@nl
P2860
P1433
P1476
The clinical and economic impa ...... -stage renal disease patients.
@en
P2093
Cathryn A Carroll
Harold J Manley
P2860
P356
10.1046/J.1525-139X.2002.00014.X
P577
2002-01-01T00:00:00Z